Health In Tech CEO gets 1.5M-share acquisition award

The grants include service-based vesting and performance conditions tied to acquisition milestones with deadlines in 2028.

Rhea-AI Filing Summary

Health In Tech, Inc. Chief Executive Officer Sanjay K. Shrestha received four stock grant awards on October 20, 2026: three awards of Class A Common Stock—2,000,000 restricted shares and two awards of 1,500,000 shares each tied to performance-based milestones—and a 500,000-share Class B Common Stock award tied to the April 30, 2028 milestone. The Class B award left reported direct holdings of 500,000 Class B shares following the transaction.

The 2,000,000 restricted shares vest in 12 equal monthly installments beginning November 1, 2026, subject to continued service. The 1,500,000-share award tied to the December 31, 2028 milestone vests in full upon closing of a qualifying acquisition, subject to continued service through closing. The other Class A award and the Class B award vest in 12 equal monthly installments, subject to continued service, if the milestone is achieved by April 30, 2028.

Insider Trade Summary

Grant/Award: 5,500,000 shares

Grant/Award 4 txns

Insider Shrestha Sanjay K

Role Chief Executive Officer

Type	Security	Shares	Price	Value
Grant/Award	Class A Common Stock F1	2,000,000	$0.00	$0.00
Grant/Award	Class A Common Stock F2	1,500,000	$0.00	$0.00
Grant/Award	Class A Common Stock F3	1,500,000	$0.00	$0.00
Grant/Award	Class B Common Stock F4	500,000	$0.00	$0.00

Holdings After Transaction: Class A Common Stock — 5,101,200 shares (Direct); Class B Common Stock — 500,000 shares (Direct)

Footnotes (4)

1. F1. Represents restricted shares granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan upon his appointment as CEO ("Shares"). Such Shares vest in twelve equal monthly installments, commencing November 1, 2026, subject to continued service through the applicable vesting date.
2. F2. Represents Shares which shall be automatically forfeited without consideration unless a performance-based acquisition milestone is achieved by December 31, 2028. Such Shares vest in full upon the closing of a qualifying acquisition, subject to continued service through such closing.
3. F3. Represents Shares which shall be automatically forfeited without consideration unless a certain performance-based milestone (the "Milestone") is achieved by April 30, 2028 (the "Achievement Date"). Such Shares vest in twelve equal monthly installments, subject to continued service. If the Achievement Date falls before the 15th calendar day of the month, vesting commences on such 15th day, and if after, commences on the 1st day of the next calendar month.
4. F4. Represents Shares which shall be automatically forfeited without consideration unless the Milestone is achieved by the Achievement Date. Such Shares vest in twelve equal monthly installments, subject to continued service. If the Achievement Date falls before the 15th calendar day of the month, vesting commences on such 15th day, and if after, commences on the 1st day of the next calendar month.

Key Figures

Class A restricted shares granted: 2,000,000 shares Class A shares granted: 1,500,000 shares Class A shares granted: 1,500,000 shares +1 more

4 metrics

Class A restricted shares granted 2,000,000 shares Vesting begins November 1, 2026, in 12 equal monthly installments, subject to continued service

Class A shares granted 1,500,000 shares Performance-based acquisition milestone by December 31, 2028; vesting in full upon closing of a qualifying acquisition, subject to continued service

Class A shares granted 1,500,000 shares Performance-based milestone by April 30, 2028; vesting in 12 equal monthly installments, subject to continued service

Class B shares granted 500,000 shares Performance-based milestone by April 30, 2028; reported direct holdings following the transaction were 500,000 shares

Key Terms

restricted shares, performance-based acquisition milestone, qualifying acquisition, automatically forfeited without consideration

4 terms

restricted shares financial

"restricted shares granted to the reporting person"

Restricted shares are company stock that cannot be sold or transferred immediately because they are subject to legal or contractual limits, such as a required holding period or performance conditions. They matter to investors because these locked-up shares can affect a company’s available stock for trading, future dilution, and insider incentives—imagine a gift that can’t be cashed until certain conditions are met, which changes when and how much supply can suddenly enter the market.

performance-based acquisition milestone financial

"performance-based acquisition milestone is achieved"

qualifying acquisition financial

"closing of a qualifying acquisition"

automatically forfeited without consideration financial

"automatically forfeited without consideration unless"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stock awards did HIT CEO Sanjay K. Shrestha receive?

On October 20, 2026, Health In Tech CEO Sanjay K. Shrestha received three Class A Common Stock awards of 2,000,000, 1,500,000 and 1,500,000 shares, plus a 500,000-share Class B Common Stock award. The awards were reported as grants.

How do Sanjay K. Shrestha’s HIT stock grants vest?

The 2,000,000 restricted shares vest in 12 equal monthly installments beginning November 1, 2026, subject to continued service. The 1,500,000-share Class A award tied to the December 31, 2028 milestone vests in full upon closing of a qualifying acquisition, subject to continued service through closing. The other 1,500,000 Class A and 500,000 Class B awards require the milestone to be achieved by April 30, 2028, and vest in 12 equal monthly installments subject to continued service.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/22/2026 - 09:24 PM EDT Accepted by SEC EDGAR 10/22/2026 - 09:23 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Shrestha Sanjay K

(Last) (First) (Middle)

701 S. COLORADO AVE

SUITE 1

(Street)

STUART FLORIDA 34994

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Health In Tech, Inc. [ HIT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	10/20/2026		A		2,000,000(1)	A	$0	2,101,200	D
Class A Common Stock	10/20/2026		A		1,500,000(2)	A	$0	3,601,200	D
Class A Common Stock	10/20/2026		A		1,500,000(3)	A	$0	5,101,200	D
Class B Common Stock	10/20/2026		A		500,000(4)	A	$0	500,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted shares granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan upon his appointment as CEO ("Shares"). Such Shares vest in twelve equal monthly installments, commencing November 1, 2026, subject to continued service through the applicable vesting date.

2. Represents Shares which shall be automatically forfeited without consideration unless a performance-based acquisition milestone is achieved by December 31, 2028. Such Shares vest in full upon the closing of a qualifying acquisition, subject to continued service through such closing.

3. Represents Shares which shall be automatically forfeited without consideration unless a certain performance-based milestone (the "Milestone") is achieved by April 30, 2028 (the "Achievement Date"). Such Shares vest in twelve equal monthly installments, subject to continued service. If the Achievement Date falls before the 15th calendar day of the month, vesting commences on such 15th day, and if after, commences on the 1st day of the next calendar month.

4. Represents Shares which shall be automatically forfeited without consideration unless the Milestone is achieved by the Achievement Date. Such Shares vest in twelve equal monthly installments, subject to continued service. If the Achievement Date falls before the 15th calendar day of the month, vesting commences on such 15th day, and if after, commences on the 1st day of the next calendar month.

	/s/ Lori Babcock, as attorney-in-fact for Sanjay Shrestha	10/22/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)